Chucair 2007
One patient, one evaluation, one success story
Understanding Anti-Aging at the Cellular Level : Anti-aging and regenerative medicine focuses on nurturing the bodys innate ability to repair and rejuvenate itself
Saxenda is approved for: Adults Adults with obesity (BMI of 30 kg/m or greater) Adults who are overweight (BMI of 27 kg/m or greater) and have at least one weight-related health condition, such as high blood pressure, type 2 diabetes, or high cholesterol Children aged 12 and older Adolescents with obesity who weigh more than 60 kg (132 pounds) Limitations of use Saxenda should not be used together with other medicines that contain liraglutide, such as Victoza, or with any other GLP-1 receptor agonist, such as Ozempic, Wegovy, or Trulicity The safety and effectiveness of Saxenda in children aged 12 to 17 years who have type 2 diabetes have not been established
But these peptides act upon our insulin signaling in a very positive way
The World Anti-Doping Agency (WADA), which regulates the drugs and other substances that elite athletes are allowed to take in and out of competition, banned the peptide in 2022 because BPC-157, according to its website, lacks current approval by any governmental regulatory health authority for human therapeutic use. But despite that regulatory action, trainers admit that they still work with elite and pro athletes who choose to take the peptide during downtime to speed recovery from injuries and surgerieswith relatively little fear of repercussions